Clinical Trials Logo

Acute B Lymphoblastic Leukemia (B-ALL) clinical trials

View clinical trials related to Acute B Lymphoblastic Leukemia (B-ALL).

Filter by:
  • None
  • Page 1

NCT ID: NCT04437420 Recruiting - Clinical trials for Acute T Lymphoblastic Leukemia (T-ALL)

Preclinical Project on the Traitment of Acute Lymphoblastique Leukemia With NVP-BEP800, an Inhibitor of the Heat Shock Protein HSP90

HSP-HEMATO
Start date: November 1, 2019
Phase:
Study type: Observational

NVP-BEP800, a new HSP90 inhibitor, has particularly interesting therapeutic potential and represents hope in cancer pathologies. While it is currently being tested for solid cancers, no preclinical study has yet demonstrated its effectiveness in acute lymphoblastique leukemia (ALL). The investigators wish to study the effects of NVP-BEP800 on two different types of ALL (T and B-ALL).